Dragos Plesca

938 total citations
17 papers, 765 citations indexed

About

Dragos Plesca is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Dragos Plesca has authored 17 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Dragos Plesca's work include Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers) and DNA Repair Mechanisms (4 papers). Dragos Plesca is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers) and DNA Repair Mechanisms (4 papers). Dragos Plesca collaborates with scholars based in United States and Australia. Dragos Plesca's co-authors include Alexandru Almasan, Suparna Mazumder, Michael Kinter, Zahra Mahmoudjafari, Kathryn A. Culos, Katie S. Gatwood, Meredith E. Crosby, Damodar Gupta, Justin Arnall and Edward A. Copelan and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Dragos Plesca

17 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dragos Plesca United States 10 410 210 105 73 58 17 765
Iman W. Achkar Qatar 10 434 1.1× 149 0.7× 124 1.2× 65 0.9× 43 0.7× 12 751
Melis Kartal Yandım Türkiye 12 659 1.6× 209 1.0× 150 1.4× 98 1.3× 82 1.4× 20 1.1k
Bing Dai China 9 293 0.7× 152 0.7× 106 1.0× 83 1.1× 44 0.8× 15 557
Peng Pu China 14 581 1.4× 111 0.5× 143 1.4× 53 0.7× 102 1.8× 39 1.0k
Sreedevi Avasarala United States 14 632 1.5× 176 0.8× 185 1.8× 78 1.1× 53 0.9× 19 967
Seyed Rouhollah Miri Iran 10 315 0.8× 104 0.5× 113 1.1× 124 1.7× 39 0.7× 18 631
Chi Hin Cho Hong Kong 13 377 0.9× 175 0.8× 84 0.8× 119 1.6× 97 1.7× 17 765

Countries citing papers authored by Dragos Plesca

Since Specialization
Citations

This map shows the geographic impact of Dragos Plesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dragos Plesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dragos Plesca more than expected).

Fields of papers citing papers by Dragos Plesca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dragos Plesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dragos Plesca. The network helps show where Dragos Plesca may publish in the future.

Co-authorship network of co-authors of Dragos Plesca

This figure shows the co-authorship network connecting the top 25 collaborators of Dragos Plesca. A scholar is included among the top collaborators of Dragos Plesca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dragos Plesca. Dragos Plesca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Moore, Donald C., et al.. (2020). Evaluation of a pharmacist-driven rapid infusion rituximab conversion protocol at a multisite cancer center. Journal of Oncology Pharmacy Practice. 27(8). 1914–1918. 3 indexed citations
2.
Patel, Jai N., Issam S. Hamadeh, Myra Robinson, et al.. (2019). Evaluation of CYP2C19 Genotype‐Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant. Clinical Pharmacology & Therapeutics. 107(3). 571–579. 29 indexed citations
3.
Hamadeh, Issam S., Qing Zhang, Nury Steuerwald, et al.. (2018). Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients. Biology of Blood and Marrow Transplantation. 25(4). 656–663. 22 indexed citations
4.
5.
Grunwald, Michael R., Danielle Boselli, Lauren Bohannon, et al.. (2018). Hypomethylating agent (HMA) treatment as a bridge to allogeneic hematopoietic cell transplantation (HCT) for relapsed/refractory acute myeloid leukemia (RR-AML).. Journal of Clinical Oncology. 36(15_suppl). 7033–7033. 1 indexed citations
6.
Moore, Donald C., Justin Arnall, & Dragos Plesca. (2018). Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting. American Journal of Health-System Pharmacy. 75(22). 1824–1830. 4 indexed citations
7.
Grunwald, Michael R., Danielle Boselli, Lauren Bohannon, et al.. (2017). Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia. Blood. 130. 3864–3864. 2 indexed citations
8.
Patel, Jai N., Myra Robinson, Issam S. Hamadeh, et al.. (2016). CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis. Blood. 128(22). 3416–3416. 2 indexed citations
9.
Fasan, Omotayo, Saad Z. Usmani, Danyu Sun, et al.. (2016). Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm. Blood. 128(22). 2184–2184. 1 indexed citations
10.
Copelan, Edward A., et al.. (2015). Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors.. PubMed. 19(104). 213–8. 1 indexed citations
11.
Chatterjee, Payel, et al.. (2013). Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragment. Nucleic Acids Research. 41(22). 10157–10169. 10 indexed citations
12.
Plesca, Dragos, Suparna Mazumder, & Alexandru Almasan. (2008). Chapter 6 DNA Damage Response and Apoptosis. Methods in enzymology on CD-ROM/Methods in enzymology. 446. 107–122. 168 indexed citations
13.
Mazumder, Suparna, Dragos Plesca, & Alexandru Almasan. (2008). Caspase-3 Activation is a Critical Determinant of Genotoxic Stress-Induced Apoptosis. Humana Press eBooks. 1219. 13–21. 328 indexed citations
14.
Plesca, Dragos, Suparna Mazumder, Vivian Gama, Shigemi Matsuyama, & Alexandru Almasan. (2008). A C-terminal Fragment of Cyclin E, Generated by Caspase-mediated Cleavage, Is Degraded in the Absence of a Recognizable Phosphodegron. Journal of Biological Chemistry. 283(45). 30796–30803. 16 indexed citations
15.
Mazumder, Suparna, Dragos Plesca, & Alexandru Almasan. (2007). A Jekyll and Hyde Role of Cyclin E in the Genotoxic Stress Response: Switching from Cell Cycle Control to Apoptosis Regulation. Cell Cycle. 6(12). 1436–1441. 32 indexed citations
16.
Plesca, Dragos, Meredith E. Crosby, Damodar Gupta, & Alexandru Almasan. (2007). E2F4 Function in G2 Maintaining G2-arrest to Prevent Mitotic Entry with Damaged DNA. Cell Cycle. 6(10). 1147–1152. 29 indexed citations
17.
Mazumder, Suparna, Dragos Plesca, Michael Kinter, & Alexandru Almasan. (2007). Interaction of a Cyclin E Fragment with Ku70 Regulates Bax-Mediated Apoptosis. Molecular and Cellular Biology. 27(9). 3511–3520. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iman W. Achkar Breakdown of academic impact, for papers by Melis Kartal Yandım Breakdown of academic impact, for papers by Bing Dai Breakdown of academic impact, for papers by Peng Pu Breakdown of academic impact, for papers by Sreedevi Avasarala Breakdown of academic impact, for papers by Seyed Rouhollah Miri Breakdown of academic impact, for papers by Chi Hin Cho
Rankless by CCL
2026